SAN DIEGO, California: A potential Alzheimer’s drug works by reducing the rate of aging at the molecular level, according to a new study by Salk Institute scientists.
The study explains how the drug both improves cognition and reduces the rate of aging, when given to very old mice.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.